← Evidence map

ReviewViruses2014

Is resistance to dolutegravir possible when this drug is used in first-line therapy?

Thibault Mesplède et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2014
2015
2016
2017
2018
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25166745